Key Highlights:
- Clover Health Investments Corp. (CLOV, Financial) will announce its Q1 2025 earnings on May 6, 2025, followed by a management-hosted conference call.
- Analysts predict an average price target of $4.15, suggesting a potential upside of 13.39% from the current stock price.
- Current brokerage consensus rates CLOV as a "Hold," with GF Value indicating a possible downside of 40.98%.
Clover Health Investments Corp. (CLOV) is poised to announce its financial results for the first quarter of 2025 on May 6, post-market close. Following the release, a detailed discussion on the company's performance and future prospects will be available via a conference call and webcast at 5:00 p.m. Eastern Time. Investors keen on insights directly from management should consider tuning in.
Wall Street Analysts Forecast
Informed by insights from five industry analysts, Clover Health Investments Corp. (CLOV, Financial) holds an average one-year price target of $4.15. This projection includes a high of $6.00 and a low of $1.75, suggesting a potential upside of 13.39% from its present trading price of $3.66. Interested investors can explore more specifics on the Clover Health Investments Corp (CLOV) Forecast page.
The collective stance from five brokerage firms yields an average recommendation rating of 2.6 for CLOV, indicative of a "Hold" position. This rating falls within a spectrum where 1 denotes a Strong Buy, and 5 suggests a Sell. The consensus reflects a cautious yet engaged investor sentiment toward the company.
According to GuruFocus metrics, the GF Value for CLOV is pegged at $2.16 for the next year, pointing to a substantial downside of 40.98% from its current valuation of $3.66. The GF Value represents GuruFocus' estimation of the fair trading value based on historical trading multiples, past growth performance, and future business forecasts. For a deeper dive into the financial data and insights, investors can visit the Clover Health Investments Corp (CLOV, Financial) Summary page.
